NeuroPace, Inc. (NPCE) Market Cap & Valuation Ratios
NeuroPace, Inc. (NPCE) has a market cap of $443.1M and a price-to-sales ratio of 4.5, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NPCENeuroPace, Inc.Follow NPCE — free
—
Price chart with a free account
- Market cap
- 443.1M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Peers
medical devices · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| NPCE | 0.4 | — | 4.6 | — | -2.6% | +12% | -15% | -27% |
| PACB | 0.7 | — | 6.7 | — | — | +2% | -84% | -22% |
| KIDS | 0.6 | — | 2.7 | — | -0.3% | +14% | -12% | -7% |
| TCMD | 0.5 | 21.9 | 1.3 | 11.2 | 5.0% | +17% | 10% | 15% |
| RCEL | 0.5 | — | 6.8 | — | -5.3% | +1.0% | -47% | -263% |
| MASS | 0.5 | — | 6.1 | — | 0.1% | +13% | -64% | -52% |
| CERS | 0.5 | — | 1.9 | — | -0.4% | +23% | -0.6% | -1% |
| OFIX | 0.4 | — | 0.6 | 37.9 | -7.0% | +3% | -5% | -7% |
| VMD | 0.4 | 27.2 | 1.2 | 7.0 | 7.8% | +25% | 8% | 12% |
| CV | 0.3 | — | 24.5 | — | -8.0% | +11% | -217% | -737% |
| QSI | 0.3 | — | 121.3 | — | — | -53% | — | -62% |
| Median of these 10 | 24.6 | 4.4 | 11.2 | -0.3% | +12% | -12% | -15% |
; EV/Sales 4.6 vs. 4.4.
Growth vs. price
each dot a company · hover or tap for valuesNeuroPace, Inc. — questions
- What is NeuroPace, Inc.'s market cap?
- $443.1M.
- What is NeuroPace, Inc.'s price-to-sales ratio?
- 4.5.
Every figure on this page comes from NeuroPace, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.